Actively Recruiting
Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block
Led by Aswan University · Updated on 2025-02-21
75
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to investigate the analgesic effect of local versus systemic dexamedetomedine as adjuvant to bupivacaine in erector spinae block in kidney exploration surgeries.
CONDITIONS
Official Title
Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing kidney exploration surgeries
- ASA physical status I or II
- Body mass index (BMI) less than 35
You will not qualify if you...
- Use of opioid analgesics before surgery
- Local infections at the injection site for the block
- ASA physical status III or IV
- Pregnancy
- History of drug addiction, alcohol abuse, or psychiatric illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aswan University
Aswān, Aswan Governorate, Egypt, 81511
Actively Recruiting
Research Team
T
Tarek s Hemaida, MD
CONTACT
S
Soudy s Hammad, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here